Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US
ByIbrahim Halil Sahin, MD,Yan Lin, PhD,Greg Yothers, PhD,Peter C. Lucas, MD, PhD,Dustin Deming, MD,Thomas J. George, MD,Scott Kopetz, MD, PhD,Christopher H. Lieu, MD,Arvind Dasari, MD, MS
Published: | Updated:
Ibrahim Halil Sahin, MD, and colleagues, explore, the CIRCULATE-US (NRG-GI008; NCT05174169) investigating postoperative ctDNA dynamics in early-stage colon cancer for treatment selection.
